Recherche
Publications

Liste complète des publications 2014-2019

Lognos B, Glondu-Lassis M, Senesse P, Gutowski M, Jacot W, Lemanski C, Amouyal M, Azria D, Guerdoux E, Bourgier C [Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy?]. Cancer Radiother. 2022;26(4):637-645. doi:10.1016/j.canrad.2021.09.011

Maran-Gonzalez A [Histoseminar: Saved by a positive staining! About the use of diagnostic biomarkers in breast pathology: case no. 6]. Ann Pathol. 2022;42(4):317-324. doi:10.1016/j.annpat.2022.01.009

Thomas Q, Quesada S, D'Hondt V, Belaroussi I, Laas E, Classe J-M, Fabbro M, Colombo P-E [Combining surgery and medical treatments for ovarian cancer: Is there an optimal strategy?]. Bull Cancer. 2022;109(2):197-215. doi:10.1016/j.bulcan.2021.11.013

Bay J-O, Bouleuc C, Firmin N, Gandemer V, Magne N, Orbach D, Penel N, Rodrigues M, Thiery-Vuillemin A, Wislez M, L'Allemain G, Sabatier R, Robert J [A 2021 inventory in oncology news]. Bull Cancer. 2022;109(1):8-19. doi:10.1016/j.bulcan.2021.12.003

Petat A, Dansin E, Calcagno F, Greillier L, Pichon E, Kerjouan M, Mennecier B, Westeel V, Thillays F, Quantin X, Oulkhouir Y, Thiberville L, Ricordel C, Thomas De Montpreville V, Chalabreysse L, Hofman V, Molina T, Fournel P, Bigay Game L, Besse B, Girard N Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network. Eur J Cancer. 2022;162. doi:10.1016/j.ejca.2021.11.028

Lavit E, Aldea M, Piperno-Neumann S, Firmin N, Italiano A, Isambert N, Kurtz J-E, Delcambre C, Lebrun V, Soibinet-Oudot P, Chevreau C, Bompas E, Le Maignan C, Boudou-Rouquette P, Le Cesne A, Mancini J, Blay J-Y, Duffaud F Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group. Int J Cancer. 2022;150(4):645-653. doi:10.1002/ijc.33823

Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno N, Prat A, Chae Y, Lee K, Niikura N, Park Y, Xu B, Wang X, Gil-Gil M, Li W, Pierga J-Y, Im S-A, Moore H, Rugo H, Yerushalmi R, Zagouri F, Gombos A, Kim S-B, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron D Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. N Engl J Med. 2022;387(1):9-20. doi:10.1056/NEJMoa2203690

Romeo C, Le Saux O, Jacobs M, Joly F, Favier L, Fumet J-D, Isambert N, Colombo P-E, Sabatier R, Bastide L, Charreton A, Devouassoux-Shisheboran M, Gertych W, Dubot C, Bello Roufai D, Bataillon G, Berton D, Kalbacher E, Pautier P, Pomel C, Cornou C, Treilleux I, Lardy-Cleaud A, Ray-Coquard I Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network. Cancers (Basel). 2022;14(2):354. doi:10.3390/cancers14020354

Rouanet P, Selvy M, Jarlier M, Bugnon C, Carrier G, Mourregot A, Colombo P-E, Taoum C Tailored Management with Highly-Selective Diversion for Low Colorectal Anastomosis: Biochemical Postoperative Follow-Up and Long-Term Results from a Single-Institution Cohort. Ann Surg Oncol. 2022;29(4):2514-2524. doi:10.1245/s10434-021-11197-2

Michalet M, Bordeau K, Cantaloube M, Valdenaire S, Debuire P, Simeon S, Portales F, Draghici R, Ychou M, Assenat E, Dupuy M, Gourgou S, Colombo P-E, Fenoglietto P, Azria D, Riou O Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study. Front Oncol. 2022;12. doi:10.3389/fonc.2022.842402

Chen T-W, Chiang R-J, Le Cesne A, Hsieh Y-C, Italiano A, Yang Y-W, Penel N, Lee W-C, Bompas E, Valentin T, Anract P, Firmin N, Duffaud F, Cheng A-L, Chan K, Blay J-Y Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan. Cancer. 2022-07-07. doi:10.1002/cncr.34372

Bobrie A, Jarlier M, Moussion A, Jacot W Sexual quality of life assessment in young women with breast cancer during adjuvant endocrine therapy and patient-reported supportive measures. Support Care Cancer. 2022;30(4):3633-3641. doi:10.1007/s00520-022-06810-3

Bourla C, Carrier G, Taoum C, Rouanet P, Colombo P Robotic-assisted colon resection for splenic flexure cancer. J Visc Surg. 2022;159(3):234-239. doi:10.1016/j.jviscsurg.2021.08.003

Guénolé A, Velilla F, Chartier A, Rich A, Carvunis A-R, Sardet C, Simonelig M, Sobhian B RNF219 regulates CCR4-NOT function in mRNA translation and deadenylation. Sci Rep. 2022;12(1):9288. doi:10.1038/s41598-022-13309-8

Jacquier V, Gitenay D, Fritsch S, Bonnet S, Gy?rffy B, Jalaguier S, Linares L, Cavaillès V, Teyssier C RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53. Cell Mol Life Sci. 2022;79(5):270. doi:10.1007/s00018-022-04277-3

Boudou-Rouquette P, Martin E, Kempf E, Penel N, Toulmonde M, Bompas E, Duffaud F, Firmin N, Bertucci F, Kurtz J-E, Isambert N, Saada-Bouzid E, Dubray-Longeras P, Larousserie F, Anract P, Chevreau C, Blay J-Y, Piperno-Neumann S Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group. Int J Cancer. 2022;150(5):825-836. doi:10.1002/ijc.33837

Edelman M, Dvorkin M, Laktionov K, Navarro A, Juan-Vidal O, Kozlov V, Golden G, Jordan O, Deng C, Bentsion D, Chouaid C, Dechev H, Dowlati A, Fernández Núñez N, Ivashchuk O, Kiladze I, Kortua T, Leighl N, Luft A, Makharadze T, Min Y, Quantin X Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer. Lung Cancer. 2022;166. doi:10.1016/j.lungcan.2022.03.003

Mangiardi-Veltin M, Sebbag C, Rousset-Jablonski C, Ray-Coquard I, Berkach C, Laot L, Wang Y, Abdennebi I, Labrosse J, Sautter C, Toussaint A, Sablone L, Laas E, Khallouch S, Coussy F, Santulli P, Chapron C, Bobrie A, Jacot W, Sella N, Dumas E, Sénéchal-Davin C, Espie M, Giacchetti S, Maitrot L, Plu-Bureau G, Coutant C, Guerin J, Asselain B, Fumoleau P, Rodrigues M, Decanter C, Mailliez A, Delrieu L, Lemoine A, Jouannaud C, Houdre D, Reyal F, Hamy A-S Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors. Reprod Biomed Online. 2022;44(6):1031-1044. doi:10.1016/j.rbmo.2021.12.019

Leenhardt F, Gauthier L, Alexandre M, Guiu S, Firmin N, Viala M, Lossaint G, Gautier C, Mollevi C, Gracia M, Mbatchi L, Evrard A, Jacot W Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual Suspects. Pharmaceutics. 2022;14(4):841. doi:10.3390/pharmaceutics14040841

Carbasse C, Leenhardt F, Jacot W, Perrier C, Viala M Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort. Br J Clin Pharmacol. 2022;88(7):3370-3377. doi:10.1111/bcp.15285

Gouzerh F, Buatois B, Hervé M, Mancini M, Maraver A, Dormont L, Thomas F, Ganem G Odours of cancerous mouse congeners: detection and attractiveness. Biol Open. 2022;11(4):bio059208. doi:10.1242/bio.059208

Fayet Y, Chevreau C, Decanter G, Dalban C, Meeus P, Carrère S, Haddag-Miliani L, Causeret S, Orbach D, Kind M, Le Nail L-R, Ferron G, Labrosse H, Bertucci F, Ruzic J-C, Le Brun Ly V, Farsi F, Bompas E, Noal S, Vozy A, Ducoulombier A, Bonnet C, Chabaud S, Ducimetière F, Tlemsani C, Ropars M, Collard O, Michelin P, Gantzer J, Dubray-Longeras P, Rios M, Soibinet P, Le Cesne A, Duffaud F, Karanian M, Gouin F, Honoré C, Coindre J-M, Ray-Coquard I, Bonvalot S, Blay J-Y No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?. Cancers (Basel). 2022;14(11):2620. doi:10.3390/cancers14112620

Kong-Hap M-A, Andrade A, Del Rio M, Pasero P, Theillet C, Gongora C, Pourquier P Multiplexed-Based Assessment of DNA Damage Response to Chemotherapies Using Cell Imaging Cytometry. Int J Mol Sci. 2022;23(10):5701. doi:10.3390/ijms23105701

Batnini K, Kirsh O, Zaroual M, Delpech H, Fallet C, Lacroix M, Le Cam L, Theillet C, Sardet C, Rodier G Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer. Int J Mol Sci. 2022;23(16):9217. doi:10.3390/ijms23169217

Müller A-K, Köhler U, Trzebanski S, Vinik Y, Raj H, Girault J-A, Ben-Chetrit N, Maraver A, Jung S, Lev S Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis. Adv Sci (Weinh). 2022;9(9):e2105696. doi:10.1002/advs.202105696



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés